Navigation
Excelsio Media by Nelson Alarcón - alarcónnelson

AstraZeneca shares dip after $39 bln Alexion deal

AstraZeneca shares dip after $39 bln Alexion deal
AstraZeneca shares fell on Monday, as investors moved to price in the British drugmaker's $39 billion deal for U.S. biotech firm Alexion Pharmaceuticals, the company's largest ever takeover and one of this year's biggest mergers globally.

Share

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

Post A Comment:

0 comments:

Leave a comment. Thanks!